Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-03 Option Award |
2025-01-07 4:04 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
40,000 | $0 | 61,400 (Direct) |
View |
| 2025-01-05 Exercise |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
10,000 | $0 | 61,400 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 8:55 pm |
2025-01-05 2034-01-04 |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
55,014 | $0 | 55,014 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:21 am |
2024-01-06 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
39,100 | $0 | 39,100 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:05 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
3,000 | $0 | 11,400 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 4:54 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
14,000 | $0 | 22,400 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 4:54 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
2,500 | $0 | 22,400 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:30 pm |
2022-02-09 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 7:21 pm |
2021-02-28 N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
1,900 | $0 | 5,900 (Direct) |
View |